AIL OLIVIER AUBEPINE BIO
Food supplement declared in France, declaration No 2018-8-653, decision dated 21 August 2018
AIL OLIVIER AUBEPINE BIO (Pharm&Nature) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Allium sativum 450 mg per day, Crataegus monogyna 450 mg per day, Olea europaea 450 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Pharm&Nature
- Food business operator placing the product on the market
- MAYOLY CONSUMER HEALTHCARE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 à 6 gélules
- Directions for use
- Prise avec un grand verre d'eau
- Not recommended (according to the manufacturer)
- Taking anticoagulants
Declaration 157503, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Allium sativum L. | Bulbe | Poudre (de plantes séchées ou broyées) | 450 mg |
| Crataegus monogyna Jacq. | Sommités fleuries | Poudre (de plantes séchées ou broyées) | 450 mg |
| Olea europaea subsp. europaea | Feuille | Poudre (de plantes séchées ou broyées) | 450 mg |
Additives
Hydroxypropyl Méthyl Cellulose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Allium sativum L.
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Crataegus monogyna Jacq.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
- Olea europaea subsp. europaea
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Ail - Olivier - Aubépine BIO Fleurance Nature, declared in 2025 : different composition: 5 ingredient(s) added, 2 missing
- AIL OLIVIER AUBEPINE BIO NATAVEA, declared in 2022 : different composition: 10 ingredient(s) added, 1 missing
- AIL OLIVIER AUBEPINE BIO AWWAOU, declared in 2019, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
Brand : Pharm&Nature
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “AIL OLIVIER AUBEPINE BIO (Pharm&Nature): composition and regulation”, https://compoatlas.com/en/supplements/products/157503-ail-olivier-aubepine-bio, updated 15 November 2026.